- Home
- NCNA vs SSKN Comparison
NCNA vs SSKN Comparison
Compare NCNA & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNA
- SSKN
- Stock Information
- Founded
- NCNA 1997
- SSKN 1989
- Country
- NCNA United Kingdom
- SSKN United States
- Employees
- NCNA N/A
- SSKN N/A
- Industry
- NCNA Biotechnology: Pharmaceutical Preparations
- SSKN Medical/Dental Instruments
- Sector
- NCNA Health Care
- SSKN Health Care
- Exchange
- NCNA Nasdaq
- SSKN Nasdaq
- Market Cap
- NCNA 7.6M
- SSKN 8.9M
- IPO Year
- NCNA 2017
- SSKN 2005
- Fundamental
- Price
- NCNA $3.82
- SSKN $1.39
- Analyst Decision
- NCNA
- SSKN Strong Buy
- Analyst Count
- NCNA 0
- SSKN 1
- Target Price
- NCNA N/A
- SSKN $6.00
- AVG Volume (30 Days)
- NCNA 76.4K
- SSKN 127.2K
- Earning Date
- NCNA 11-13-2025
- SSKN 11-13-2025
- Dividend Yield
- NCNA N/A
- SSKN N/A
- EPS Growth
- NCNA N/A
- SSKN N/A
- EPS
- NCNA N/A
- SSKN N/A
- Revenue
- NCNA N/A
- SSKN $30,980,000.00
- Revenue This Year
- NCNA N/A
- SSKN N/A
- Revenue Next Year
- NCNA N/A
- SSKN $9.70
- P/E Ratio
- NCNA N/A
- SSKN N/A
- Revenue Growth
- NCNA N/A
- SSKN N/A
- 52 Week Low
- NCNA $2.78
- SSKN $1.24
- 52 Week High
- NCNA $330.00
- SSKN $3.86
- Technical
- Relative Strength Index (RSI)
- NCNA 50.98
- SSKN 41.96
- Support Level
- NCNA $3.10
- SSKN $1.24
- Resistance Level
- NCNA $3.88
- SSKN $1.46
- Average True Range (ATR)
- NCNA 0.28
- SSKN 0.10
- MACD
- NCNA 0.07
- SSKN -0.01
- Stochastic Oscillator
- NCNA 81.19
- SSKN 30.61
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.